Ceftriaxone for treatment of ALS

• A clinical trial of an antibiotic for people diagnosed with ALS. May slow the progression of disease.

• Enrollment open
• Diagnosed with ALS
• Vital capacity (breathing) at least 60% of normal
• IV Drug administered through an implanted catheter
• Monthly study visits

Trial of high fat/ high calorie diet versus optimal calorie replacement in ALS

• A clinical trial to evaluate the effect of diet on the progression of ALS

• Enrollment Open
• Diagnosed with ALS
• Have feeding tube and ability to tolerate tube feeds
• On Bi-pap for less than 10 hours per day
• No allergies to soy, fish or milk products
• Participation of 5.5 months

Latoya Shaw
404-727-1673
latoya.q.shaw@emory.edu

or

Crystal Kelly
404-727-1638
crystal.kelly@emory.edu